Follow the 三友医疗 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 三友医疗 has recorded 17 reports. Market capitalisation: €4.5bn. The latest transaction was reported on 18 March 2026 (Sale). Among the most active insiders: Michael Mingyan Liu. Every trade is accessible without an account.
17
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
11 ops.
Sell Volume
14Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,008 of 25,451 companies
49.0
score / 100
Value
29
Quality
69
FCF yld0.8%
Earn yld1.4%
EV/EBITDA49.2x
ROE1.7%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.